Abstract Introduction
Prevention of overweight and obesity in childhood is a priority because of associated acute and chronic conditions in childhood and later in life, which place significant burden on health systems. Evidence suggests prevention should engage a range of actions and actors and target multiple levels. The Whole of Systems Trial Of Prevention Strategies for childhood obesity (WHO STOPS) will evaluate the outcomes of a novel systems-based intervention that aims to engage whole communities in a locally led multifaceted response. This paper describes the planned economic evaluation of WHO STOPS and examines the methodological challenges for economic evaluation of a complex systems-based intervention.
Methods and analysis
Economic evaluation alongside a stepped wedge cluster RCT in regional and rural communities in Victoria, Australia. Cost-effectiveness and cost-utility analyses will provide estimates of the incremental cost (in Australian dollars) per body mass index (BMI) unit saved and quality adjusted life year (QALY) gained. A Markov cohort model will be employed to estimate healthcare cost savings and benefits over the life course of children. The dollar value of community resources harnessed for the community-led response will be estimated.
Probabilistic uncertainty analyses will be undertaken to test sensitivity of results to plausible variations in all trial-based and modelled variables. WHO STOPS will also be assessed against other implementation considerations (such as sustainability and acceptability to communities and other stakeholders).
Ethics and dissemination
The trial is registered by the Australian New Zealand Clinical Trials Registry 
Strengths and limitations of this study
• This protocol describes the methods for assessing the cost-effectiveness of WHO STOPS, a systems-based childhood obesity prevention intervention, from the funder/organiser and societal perspectives.
• The WHO STOPS intervention effect on childhood BMI will be identified using a stepwedge, cluster-randomised controlled trial design.
• This is a novel and complex intervention that poses many challenges for economic evaluation, including defining boundaries around the intervention; identification and measurement of costs and appropriate attribution of costs to WHO STOPS.
• A range of data collection approaches will be employed to identify and measure the resources contributed across multiple sectors in participating communities.
• Given the nature of the intervention and its engagement complexity, this economic evaluation will employ and assess novel approaches for assessing costs and cost effectiveness. Building on the existing evidence, the Whole of Systems Trial Of Prevention Strategies for childhood obesity (WHO STOPS) will evaluate the impact of a novel intervention that aims to engage whole communities in a locally led multifaceted response (Allender et al. 2016 ). This systems-based intervention is underpinned by systems thinking (Hovmand 2014; Sterman 2000) and collective impact (Allender et al. 2016 ; Kania & Kramer 2011) . WHO STOPS aims to reduce childhood BMI-z and obesity prevalence by supporting community leaders to 
From the funder/organiser and societal perspectives, what is the cost-effectiveness of the WHO STOPS childhood obesity intervention compared with current practice in
regional and rural communities in Victoria, Australia?
About the trial

Study design
WHO STOPS is a stepped-wedge, cluster randomised controlled trial (C-RCT). The trial design is described in detail in Allender et al. (2016) . In brief, ten dispersed clusters or 'natural communities' (based on existing local government, health service and education boundaries) in the South Western Region of Victoria (Australia) were randomly assigned to receive the intervention at Step 1 (2017) -referred to as intervention communities, or Step 2 (2019) referred to as control communities (See Table 1 ). Note the timing of implementation has been updated from Allender et al. (2016) . The region has 360,000 inhabitants and population clusters range in size from around 3,200 to 20,800 people.
The intervention
The intervention has three main components.
(1) Community engagement and facilitation (Component One)
Firstly, community leaders will engage in at least two Group Model Building (GMB) sessions. The research team will facilitate the construction of a causal loop diagram (CLD) that visually describes from the community leaders' points of view, the shared understanding of the drivers of childhood obesity in their community and the interactions between such drivers (Hovmand 2014; Sterman 2000; Vennix 1996) . Figure 1 provides an example of a community leaders' CLD (Allender et al. 2015 ). All community members are then invited to participate in a whole of community session (or sessions), where participants will (a) review the CLD, (b) identify points across the CLD where community-led actions to reduce obesityrelated risk factors can be designed and implemented, and (c) form community action groups to take ownership of these proposed actions. Built on a behavioural and anthropometry school based monitoring program, childhood obesity and associated risk factor data collected in primary schools of the same community Kramer 2011) which seeks to identify and support a local "backbone" organisation that will take significant responsibility for fostering, supporting and monitoring the community-led actions (described in Component Three). It is anticipated that this role will include facilitating WHO STOPS action planning and review meetings, tracking and providing feedback of community-led actions to the community. During a pilot testing phase in a proximal, comparable town, the backbone organisation was a locally-based public health organisation that allocated personnel time to these tasks.
Components One and Two capture the reproducible element of the intervention and will be directly facilitated by the implementation specialists from the WHO STOPS research team.
The timing of the establishment of the backbone organisation however, may occur prior to, during or after Component One. The end of the whole of community session(s), where community-led actions are agreed upon, will mark the full implementation of the intervention dose.
(3) Community-led actions (Component Three).
Component Three consists of the planning and implementation by community members, of the suite of actions identified in their whole of community sessions, as well as any actions subsequently taken in the community that were motivated by Component One. The aim will be to undertake numerous actions across multiple points in the community thereby addressing a range of obesity-related risk factors. Actions might be led by community organisations (including local government, health services, schools and sporting clubs), businesses, community groups or individuals. Any resources required to implement proposed actions will be sourced by communities, primarily from within existing community resources. This strategy will result in Component Three being unique in each of the five intervention communities.
Control communities
Current practice will be observed in control (
Step 2) communities. This will include any local strategies targeting obesity-related risk factors implemented at the community level. Current practice itself is dynamic as communities introduce new and phase out old local strategies. Implementation of the intervention in control communities will be completed two years after implementation in intervention (Step 1) communities (2019) (see Table 1 ). 
Challenges for conducting economic evaluation of a whole of system intervention
The characteristics of this novel systems-based childhood obesity prevention strategy introduce a number of practical challenges for the application of standard economic evaluation methods.
Defining the intervention
From the funder/organiser perspective, the intervention could be viewed as limited to Component One, with the establishment of a Backbone organisation (Component Two) and the range of community actions generated (Component Three) -important intermediate outcomes. However, from a broader societal perspective, those (Component Three) community actions are a prerequisite for obesity-related behaviour change and as such can be considered an active component of the intervention. From this perspective, understanding the resources harnessed from within the community to affect any potential change in childhood overweight and obesity is important. Adding further complexity, each community will develop its own non-prescribed set of actions -as a result of differing priorities (determined via Component One), and at least partly as a result of the capacity provided by their backbone organisation and the approach it takes. As a result, each community's Component Three will be unique, non-standardised and tailored to its own specific needs and resource capacity.
Assessing the costs
Whilst costing Components One and Two will be relatively straightforward, the task of costing Component Three will be large and complex. Implemented actions (Component Three) will occur across numerous sectors/settings (e.g. health, education, local 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  p  e  e  r  r  e  v  i  e  w  o  n  l  y   10 government, transport, local commerce, sport and recreation), making identification of costs difficult. Implementing parties may be well-defined (e.g. local department of health, local municipal government, school, sports club) or smaller and informal (e.g. households or a group of parents). Beyond identification, "best practice" micro-costing of the potentially hundreds of discrete actions that may result across multiple communities, is not feasible given this and most research projects' resource constraints.
Attributing costs of a community action to the intervention in itself provides challenges particularly when:
(a) an action has a set of aims and/or targets group broader than children;
(b) an action was motivated by observing other activities in theirs or other communities, rather than resulting from participation at the original community GMB sessions (i.e.
how many degrees of separation should be allowed for spin-off actions to be included?);
(c) the intervention was only a tipping point, where years of community attention afforded a given action brought the community to a point of readiness to implement; and (d) an action is somewhat distal to the primary aim of the intervention but was identified as an obesity-related risk factor by that community (e.g. targeting parental drug and alcohol use to improve parenting skills).
Whilst not unique to this intervention, this research is part of a much larger research effort and there is a genuine risk of overburdening community members with data collection at the risk of undermining community support (Gubbels et al. 2015) . The costing method applied requires achievement of a balance between data comprehensiveness, feasibility and community sensitivity.
Assessing the benefits.
The benefits of the whole of systems intervention may extend beyond the primary outcome and target population. shifts (the potential use of which will be explored in this trial).
Lessons from the literature.
The CHEERS guidelines for reporting economic evaluations (Husereau et al. 2013 
Methods and analysis
Economic evaluation overview
A cost-effectiveness evaluation will be conducted with incremental cost-effectiveness ratios and any treatment effect. Costs and benefits will be modelled over the rest-of-life, until the study cohort of children has either died or reached 100 years of age. The dollar value of community resources harnessed for $1 investment into Component One will also be estimated. All costs will be inflated to current Australian dollars for the year of study completion using the all-items Consumer Price Index from the Australian Bureau of Statistics. All costs and benefits will be converted to present values using an annual discount rate of 5% in the base-case, and annual rates of 3.5% and 0% in sensitivity analysis (Department of Health, 2016). Given the burden associated with costing, the costing of Components Two and Three will be restricted to two intervention communities and two control communities. These will be selected by the research team in consultation with external partners using the following considerations: (i) there is comparability in the population size of intervention and control communities, (ii) the selected communities have some generalisability from the perspective of decision-makers, and most importantly (iii) backbone organisation agrees to participate in data provision and collection for the economic evaluation. To capture broader less quantifiable issues that are of concern to policymakers, WHO STOPS will also be assessed against other implementation considerations (strength of evidence, equity, acceptability to stakeholders, sustainability, feasibility of implementation, and potential side effects) as per the approach developed and employed by Carter et al (2009) . These will be assessed by the research team in consultation with backbone organisations and other community partners.
Identification, measurement and valuation of Outcomes
Health and health-related behavioural outcomes. 
Quality of life
Health-related quality of life (HRQoL) data will be collected (see Crooks HRQoL instrument, an algorithm will be developed using best practice methods, to enable conversion of PedsQL overall scores of study participants to the preference-based
Children's Health Utility 9 Dimension (CHU-9D) index (Stevens 2012; Wailoo et al. 2017 ).
This will enable estimation of any resulting QALY gains (Wailoo et al. 2017 ).
System changes
Proxy indicators of system change will be measured at baseline and followed-up annually.
The number of community actions will be tracked (and dollar value of resources utilised estimated) as proxies of community level engagement. Social network analysis (SNA) methods will be used to measure structural changes in community leadership networks (Valente et al. 2015) . Assessments of changes in the obesity policy, infrastructure and leadership environment will be measured through a readiness to change (RTC) analysis (Plested et al. 2006) . These indicators will inform analysis of the other implementation considerations.
Future health and HRQoL benefits
An existing multi-state life table Markov model will be used. Described in detail in Brown (2017), the model estimates (for the 2010 Australian population) the extent to which changes in BMI and physical activity (independent of BMI), impact on the incidence and associated health care costs of osteoarthritis of the knee and hip, breast cancer, colon cancer, endometrial cancer, kidney cancer, ischaemic heart disease, hypertensive heart disease, stroke and type 2 diabetes; all causally related to obesity. The model was built in Excel Table 2 summarises the cost inclusions and data collection strategy for Components One, Two and Three. The planned approach for identification and measurement of costs will utilise a community's backbone organisation to track community actions and collect data on related resource use for planning and implementation of given actions. This approach has been developed in collaboration with team members of such a backbone organisation and takes into consideration their capacity to collect data for research purposes, which may be beyond their own data needs for evaluation and community feedback. Table 2 . Cost inclusions and sources of costing data. Annually. Costs included:
Identification and measurement of costs
Component 3 (Community-led actions)
• person-time (planning and implementing actions; followup meetings of community progress),
• venue hire, and equipment (e.g. cooking equipment, sporting equipment),
• Infrastructure investment (e.g. community garden, water fountain, bike path). Should an action result in an organisation moving funds between obesity-related programmes (i.e. no net change in obesity-related programme funding), the costs associated with the newly funded activity will not be included in the cost-effectiveness analysis, though the new activity will be identified and documented. Given the intractability of such datachanges in household expenditure on food and physical activity, and changes in revenue flowing to local retailers as a result of Component Three actions will be excluded. The costs of designing and developing the process for engaging and facilitating community actions (Component One), and STICK-E will be excluded as they largely pre-exist this trial and will have wider use beyond this childhood obesity prevention intervention. The collection of resource use data relating to current practice in the control communities will differ in some respects. Backbone organisations will not be actively established by the research team until close to Step 2 implementation. This will minimise researcher-led contamination of the control communities, but will result in a reliance on retrospective identification of community actions in those communities (as set out in Table 1 ) and raises the risk of failing to identify "current practice" actions that occurred. This potential for recall bias reinforces the importance of taking steps to assess attribution of actions to WHO STOPS in the intervention communities.
Valuation of resource use
The time contributions of individuals (professional and volunteer time) will be costed using opportunity cost principles. Resource use of non-health sector goods and services will be Where the data collection strategy results in insufficient detail for an identified community action, evidence of costs may be drawn from comparable community-based obesity prevention activities. The anticipated large number of community-led actions likely to be identified and logged in a backbone's action register will deem it infeasible to collect detailed data on resource use for each registered action. As such, each action will be classified into small, medium and large (in terms of resource intensity) by backbone organisation personnel. A sample from each classification will then be costed in detail, with results extrapolated.
Uncertainty and scenario analyses
It is possible that other family members of targeted children and the broader community may also benefit from the WHO STOPS intervention in terms of BMI change (Frew 2016) .
Furthermore, the intervention may result in (a) productivity gains given potentially reduced child absenteeism from school for obesity-related reasons leading to lower parent absenteeism from work, and (b) improved future income levels arising from improved schooling outcomes (Black et al 2015; Cawley 2010) . Best available evidence on such broader potential costs and benefits will be sought and included in scenario analyses.
Extensive analyses will be undertaken to test the sensitivity of results to plausible variations in all trial-based and modelled variables, including assumptions around the maintenance of any observed changes in BMI, PA and fruit and vegetable consumption as well the costs of alternative approaches to GMB facilitation (where local community members are trained to facilitate). Further, in the event that BMI changes are observed in children, the potential impact on the intervention's cost-effectiveness of broader "family effects" will be investigated in scenario analyses. The potential for system dynamics models to estimate the impact of "system-wide" changes on future obesity-related behaviours and prevalence will be explored and considered for use in scenario analyses.
Conclusion
Obesity is associated with poorer health and quality of life -its prevalence is high and rising 
Methods and analysis
Ethics and dissemination
The trial is registered by the Australian New Zealand Clinical Trials Registry (ACTRN12616000980437). Full ethics clearances have been received for all methods described below: Deakin University's Human Research Ethics Committee (DU-HREC) 2014-
279, Deakin University's Human Ethics Advisory Group-Health (HEAG-H) HEAG-H 194_2014, HEAG-H 17 2015, HEAG-H 155_2014, HEAG-H 197_2016, HEAG-H 118_2017), the Victorian Department of Education and Training 2015_002622 and the Catholic
Archdiocese of Ballarat. Trial findings (including economic evaluation) will be published in peer reviewed journals and presented at international conferences. Collected data and analyses will be made available in accordance with journal policies and study ethics approvals. Results will be presented to relevant government authorities with an interest in cost effectiveness of these types of interventions. 
Strengths and limitations of this study
• The protocol for this novel and complex intervention is guided by the CHEERS guidelines for economic evaluation and draws lessons from literature on the economic evaluation of complex public health interventions.
• Pragmatic solutions are discussed for the core challenges this complex intervention poses for economic evaluation (e.g. defining intervention boundaries; measurement and attribution of costs to WHO STOPS).
• WHO STOPS will be assessed against other implementation considerations (strength of evidence, equity, acceptability to stakeholders, sustainability, feasibility of implementation, and potential side effects).
• This protocol provides the core elements for the economic evaluation of this adaptive multifaceted whole of systems approach. Further decisions may be required that have not yet been considered. 
Introduction
Childhood obesity causes a range of acute and chronic conditions reducing mental and physical health and wellbeing. [1] [2] [3] Obese children are at higher risk of becoming obese adults, a major risk factor for diabetes, cardiovascular disease and some cancers. [1, 4, 5] The World Health Organisation (WHO) estimates that 23% of children living in developed countries are overweight or obese. [6] In Australia, the most recent National Health Survey (2014-15) indicates that 27% of children aged 7-12 years are overweight or obese. [7] It is estimated the direct costs of obesity to the health system were $8.6 billion in the 2011/12 financial year. [8] Preventing the onset of overweight and obesity during childhood could improve physical and psychological wellbeing, and education outcomes for children; and reduce the health burden and health care costs during childhood and later life. [9] [10] [11] [12] While many different types of interventions to prevent or treat childhood obesity have been trialled. [13, 14] these have generally shown limited feasibility and/or success. In the absence of successful interventions, invasive procedures such as bariatric surgery have increasingly been used to reduce body mass index (BMI) in teens with obesity as well as children as young as nine years. [15] However, these procedures are costly to the health system and are a high-risk rather than population-level solution. [9] Downstream interventions targeting atrisk children and their parents through screening and provision of primary-care based interventions have generally been ineffective in reducing BMI. [16] Of the more upstream interventions, few achieved reductions in the BMI of children, [13] and those that did, have not demonstrated long term benefits. [13, 17] The most promising strategies for preventing childhood obesity appear to be multifaceted -engaging a range of actions and actors to target multiple risk-factors across multiple levels (e.g. individuals, schools and whole communities). [13, 18] Building on the existing evidence, the Whole of Systems Trial Of Prevention Strategies for childhood obesity (WHO STOPS) will evaluate the impact of a novel intervention that aims to engage whole communities in a locally led multifaceted response. [19] This systems-based intervention is underpinned by systems thinking [20, 21] and collective impact. [19, 22] WHO STOPS aims to reduce childhood BMI-z and obesity prevalence by supporting community leaders to change food and physical activity (PA) environments, and related behaviours. [19] Assessing cost-effectiveness of new interventions is critical to priority setting and funding decisions. [23] [24] There are few trials employing systems-based thinking for childhood obesity prevention and consequently little rigorous evaluation of cost-effectiveness of these approaches. [25] This is due to the relatively recent emergence of this approach to childhood 
About the trial
Study design
WHO STOPS is a stepped-wedge, cluster randomised controlled trial (C-RCT). The trial design is described in detail in Allender, et al. 19 In brief, ten dispersed clusters or 'natural communities' (based on existing local government, health service and education boundaries)
in the South Western Region of Victoria (Australia) were randomly assigned to receive the intervention at Step 1 (2017) -referred to as intervention communities, or Step 2 (2019) referred to as control communities (See Table 1 ). Note the timing of implementation has been updated from Allender et al. (2016) . The region has 360,000 inhabitants and population clusters range in size from around 3,200 to 20,800 people.
The intervention
(1) Community engagement and facilitation (Component One)
Firstly, community leaders will engage in at least two Group Model Building (GMB) sessions.
The research team will facilitate the construction of a causal loop diagram (CLD) that visually describes from the community leaders' points of view, the shared understanding of the drivers of childhood obesity in their community and the interactions between such drivers. [20, 21, 31 ] Figure 1 provides an example of a community leaders' CLD. [32] All community members are then invited to participate in a whole of community session (or sessions), where participants will (a) review the CLD, (b) identify points across the CLD where community-led actions to reduce obesity-related risk factors can be designed and implemented, and (c) form community action groups to take ownership of these proposed actions. Built on a behavioural and anthropometry school based monitoring program, childhood obesity and associated risk factor data collected in primary schools of the same community (see Crooks, et al. [33] ) will be presented during the GMB and whole of community sessions.
(2) Backbone organisation (Component Two)
The WHO STOPS process uses a collective impact approach, [19, 22] which seeks to identify and support a local "backbone" organisation that will take significant responsibility for fostering, supporting and monitoring the community-led actions (described in Component Three). It is anticipated that this role will include facilitating WHO STOPS action planning and review meetings, tracking and providing feedback of community-led actions to the community. During a pilot testing phase in a proximal, comparable town, the backbone organisation was a locally-based public health organisation that allocated personnel time to these tasks.
(3) Community-led actions (Component Three).
Component Three consists of the planning and implementation by community members, of the suite of actions identified in their whole of community sessions, as well as any actions subsequently taken in the community that were motivated by Component One. The aim will be to undertake numerous actions across multiple points in the community thereby addressing a range of obesity-related risk factors. Actions might be led by community organisations (including local government, health services, schools and sporting clubs), businesses, community groups or individuals. Any resources required to implement proposed actions will be sourced by communities, primarily from within existing community resources. This strategy will result in Component Three being unique in each of the five intervention communities. 
Control communities
Step 2) communities. This will include any local strategies targeting obesity-related risk factors implemented at the community level. Current practice itself is dynamic as communities introduce new and phase out old local strategies.
Implementation of the intervention in control communities will be completed two years after implementation in intervention (Step 1) communities (2019) (see Table 1 ). 
Challenges for conducting economic evaluation of a whole of system intervention
Defining the intervention
From the funder/organiser perspective, the intervention could be viewed as limited to the resources harnessed from within the community to affect any potential change in childhood overweight and obesity is important. Adding further complexity, each community will develop its own non-prescribed set of actions -as a result of differing priorities (determined via Component One), and at least partly as a result of the capacity provided by their backbone organisation and the approach it takes. As a result, each community's Component Three will be unique, non-standardised and tailored to its own specific needs and resource capacity.
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Assessing the costs
Whilst costing Components One and Two will be relatively straightforward, the task of costing Component Three will be large and complex. Implemented actions (Component Three) will occur across numerous sectors/settings (e.g. health, education, local government, transport, local commerce, sport and recreation), making identification of costs difficult. Implementing parties may be well-defined (e.g. local department of health, local municipal government, school, sports club) or smaller and informal (e.g. households or a group of parents). Beyond identification, "best practice" micro-costing of the potentially hundreds of discrete actions that may result across multiple communities, is not feasible given this and most research projects' resource constraints.
Whilst not unique to this intervention, this research is part of a much larger research effort and there is a genuine risk of overburdening community members with data collection at the risk of undermining community support. [34] The costing method applied requires achievement of a balance between data comprehensiveness, feasibility and community sensitivity.
Assessing the benefits.
The benefits of the whole of systems intervention may extend beyond the primary outcome and target population. For example, any resulting improvement in a child's eating and PA behaviours may extend to other household members; [35] or the strengthening of a community's networks and leadership may improve its capacity to address other health and the trial period is difficult. These innovative intervention strategies require novel assessment techniques or adaptation of existing methods. Scenario analyses using system dynamics models [37] may provide a framework to predict the likelihood of such system shifts (the potential use of which will be explored in this trial).
Lessons from the literature.
The CHEERS guidelines for reporting economic evaluations [26] remain generally appropriate for this systems-based intervention, and some relevant lessons can be drawn from economic evaluations of complex public health interventions that share some of these challenges. [35, [38] [39] [40] [41] [42] However, the level of detail embedded in these resources is insufficient to provide practical guidance on all of the methodological decisions required. [43] Frew [35] argues (in the context of childhood obesity interventions) that such challenges require creativity, with decision rules made and justified on a case-by-case basis, whilst keeping the needs of decision-makers foremost in mind.
Methods and analysis
Economic evaluation overview
A cost-effectiveness evaluation will be conducted with incremental cost-effectiveness ratios (ICER) calculated for the cost ($AUD) per BMI unit saved and quality adjusted life year (QALY) gained. Results will be analysed at the commencement of Step 2 implementation (2019), when a comparison of the intervention versus current practice can be made. Results will also be analysed after four years (two years post Step 2 implementation (2021)) to identify the evolution and sustainability of community responses (including resource use) and any treatment effect. Analyses of intention-to-treat and as-per-protocol (i.e. reaching Component 3) treatment effects will be undertaken. Costs and benefits will be modelled over the rest-of-life, until the study cohort of children has either died or reached 100 years of age.
The dollar value of community resources harnessed for $1 investment into Component One will also be estimated. All costs will be inflated to current Australian dollars for the year of study completion using the all-items Consumer Price Index from the Australian Bureau of Statistics. All costs and benefits will be converted to present values using an annual discount rate of 5% in the base-case, and annual rates of 3.5% and 0% in sensitivity analysis. [44] Depending on the funding source of the identified backbone organisations, it is possible this funder/organiser perspective will overlap significantly with a state government perspective.
Secondly, a societal perspective will be taken, which will include the costs of resources contributed by the broader community through Component Three, as well as future health system cost offsets. Whilst it is expected that community actions will largely be resourced by reallocations of existing resources and funds, the associated opportunity costs require identification. This perspective will be of value for funding decision-making at higher levels (e.g. state, national) where broader comparisons of relative cost-effectiveness within and across health silos are made, as well as for communities considering such a strategy, so they are fully aware that any treatment effect observed in this trial may have been mediated by the scale of community resources (e.g. volunteer hours) contributed in those communities.
Given the burden associated with costing, the costing of Components Two and Three will be restricted to two intervention communities and two control communities. These will be selected by the research team in consultation with external partners using the following considerations: (i) there is comparability in the population size of intervention and control communities, (ii) the selected communities have some generalisability from the perspective of decision-makers, and most importantly (iii) backbone organisation agrees to participate in data provision and collection for the economic evaluation. To capture broader, less quantifiable issues that are of concern to policymakers, WHO STOPS will also be assessed against other implementation considerations (strength of evidence, equity, acceptability to stakeholders, sustainability, feasibility of implementation, and potential side effects) as per the approach developed and employed by Carter, et al. [45] These will be assessed by the research team in consultation with backbone organisations and other community partners.
Identification, measurement and valuation of Outcomes
Health and health-related behavioural outcomes. Primary (BMI change) and secondary (PA and dietary behaviours) outcome data will be collected from children aged between about 8 and 12 years at participating primary schools using opt-out (passive) consent as described in Crooks, et al. [33] and the intervention effect assessed as described in Allender, et al. [19] PA and dietary behaviour questions will be selfcompleted, with students given structured prompts on how to answer the questions or to clarify terminology (as is the case for health-related quality of life (HRQoL) questionnairediscussed below).
Quality of life
HRQoL data will be collected (see Crooks, et al. [33] ) using the PedsQL TM 4.0 Child Report (8-12 years) . The PedsQL is a non-preference-based 23 item instrument that assesses functioning across physical, emotional, social and school domains, where responses are transformed to a score on a 0-100 scale; higher scores reflect better HRQoL. [46] Given PedsQL is a non-preference-based HRQoL instrument, an algorithm will be developed to enable conversion of PedsQL overall scores of study participants to the preference-based
Children's Health Utility 9 Dimension (CHU-9D) index [47, 48] . Specifically, a dataset of around 1800 Australian children aged between 10 and 12 years will be employed. Following best practice methods, the optimal mapping algorithm will be chosen based on a series of econometric techniques using a number of goodness-of-fit measures. [47] This will enable estimation of any resulting QALY gains. [47] System changes Proxy indicators of system change will be measured at baseline and followed-up annually.
The number of community actions will be tracked (and dollar value of resources utilised estimated) as proxies of community level engagement. Social network analysis (SNA) methods will be used to measure structural changes in community leadership networks. [49] Assessments of changes in the obesity policy, infrastructure and leadership environment will be measured through a readiness to change (RTC) analysis. [50] These indicators will inform analysis of the other implementation considerations.
Future health and HRQoL benefits
An existing multi-state life table Markov model will be used. Described in detail in Brown, et al., [51] the model estimates (for the 2010 Australian population) the extent to which changes in BMI and physical activity (independent of BMI), impact on the incidence and associated health care costs of osteoarthritis of the knee and hip, breast cancer, colon cancer, endometrial cancer, kidney cancer, ischaemic heart disease, hypertensive heart disease, stroke and type 2 diabetes; all causally related to obesity. The model was built in Excel Table 2 summarises the cost inclusions and data collection strategy for Components One, Two and Three. The planned approach for identification and measurement of costs will utilise a community's backbone organisation to track community actions and collect data on related resource use for planning and implementation of given actions. A community action register, which is designed for tracking community actions and associated resource use, will be provided to each community's backbone organisation. This will facilitate data collection for economic evaluation purposes as well as aid each community's own monitoring and evaluation. This approach has been developed in collaboration with team members of such a backbone organisation and takes into consideration their capacity to collect data for research purposes, which may be beyond their own data needs for evaluation and community feedback. Annually. Annually. Should an action result in an organisation moving funds between obesity-related programmes (i.e. no net change in obesity-related programme funding), the costs associated with the newly funded activity will not be included in the cost-effectiveness analysis, though the new activity will be identified and documented. Given the intractability of such datachanges in household expenditure on food and physical activity, and changes in revenue flowing to local retailers as a result of Component Three actions will be excluded. The costs of designing and developing the process for engaging and facilitating community actions (Component One), and STICK-E will be excluded as they largely pre-exist this trial and will have wider use beyond this childhood obesity prevention intervention.
Identification and measurement of costs
Component 3 (Community-led actions)
Included costs
To assess the extent to which an identified action is attributable to WHO STOPS, at least Given the intrinsic variability of component three of the intervention, it is possible that comprehensive costing of only two of the five communities might not provide an accurate representation of the potentially large between-community heterogeneity of actions and costs involved in this component. As a way to investigate this variability all communities will be encouraged to monitor community actions and resource contributions using the community action register. Prior to finishing the economic evaluation, results from the costing of the two selected intervention communities will be discussed with backbone organisations from all intervention communities. Those backbone organisations from communities not comprehensively costed will be asked to consider those results alongside the actions registered in their own registers, and reflect on the extent to which findings appear consistent with their own communities. If perceived heterogeneity is raised, this will be acknowledged as a limitation in the published economic evaluation results. The collection of resource use data relating to current practice in the control communities will differ in some respects. Backbone organisations will not be actively established by the research team until close to Step 2 implementation. This will minimise researcher-led contamination of the control communities, but will result in a reliance on retrospective identification of community actions in those communities (as set out in Table 1 ) and raises the risk of failing to identify "current practice" actions that occurred. This potential for recall bias reinforces the importance of taking steps to assess attribution of actions to WHO STOPS in the intervention communities.
Valuation of resource use
The time contributions of individuals (professional and volunteer time) will be costed using opportunity cost principles. Resource use of non-health sector goods and services will be valued at market prices and be informed by best available evidence from Australian based studies. Where relevant, health resources will be costed as per the Manual of Resource
Items for use in submissions to the Commonwealth of Australia's Pharmaceutical Benefits Advisory Committee. [44] Where the data collection strategy results in insufficient detail for an identified community action, evidence of costs may be drawn from comparable community-based obesity prevention activities. The anticipated large number of community-led actions likely to be identified and logged in a backbone's action register will deem it infeasible to collect detailed data on resource use for each registered action. As such, each action will be classified into small, medium and large (in terms of resource intensity) by backbone organisation personnel. A sample from each classification will then be costed in detail, with results extrapolated.
Uncertainty and scenario analyses
It is important to note some of the challenges being faced that may have implications for the estimated treatment effect. The intervention aims to make system level changes, some of which will take longer than the trial period to occur. Further, due to the variability we have observed in the time it takes communities to reach the Component 3 stage (community actions), it is likely there will be variable effects measured across communities after two years. The four year analyses to be undertaken will be comparing a maximum of four years communities) rather than comparing against a current practice control. However, BMI change data is being collected from a small number of schools in 13 communities external to the WHO STOPS study. [52] The methods of data collection and general characteristics of the surveyed schools differ from the current study. While these external communities do not constitute the ideal control group, several of the external communities are comparable (in terms of population and geographic proximity to major urban centres). The external communities will provide an indication of BMI trends in non WHO STOPS settings. This will facilitate the estimation of plausible variations in treatment effects at 2 and 4 years for use in sensitivity analyses.
It is possible that other family members of targeted children and the broader community may also benefit from the WHO STOPS intervention in terms of BMI change. [35] Furthermore, the intervention may result in (a) productivity gains given potentially reduced child absenteeism from school for obesity-related reasons leading to lower parent absenteeism from work, and (b) improved future income levels arising from improved schooling outcomes. [53, 54] Best available evidence on such broader potential costs and benefits will be sought and included in scenario analyses.
Given uncertainty around the maintenance of community responses and treatment effects beyond the trial period, modelling of future benefits and health cost savings will test a range of plausible assumptions of decayed and maintained treatment effect. These may range from full decay over 5 or 10 years through to 100% maintenance of effect. In the event that within trial analyses of the proxy indicators of system change suggest an accentuation of treatment effect is plausible, modest accentuation of treatment effect will also be modelled.
Extensive analyses will be undertaken to test the sensitivity of results to plausible variations in all trial-based and modelled variables, including assumptions around the maintenance of any observed changes in BMI (as discussed above), PA and fruit and vegetable consumption as well the costs of alternative approaches to GMB facilitation (where local community members are trained to facilitate). Further, in the event that BMI changes are observed in children, the potential impact on the intervention's cost-effectiveness of broader "family effects" will be investigated in scenario analyses. The potential for system dynamics models to estimate the impact of "system-wide" changes on future obesity-related behaviours and prevalence will be explored and considered for use in scenario analyses. 
Conclusion
Obesity is associated with poorer health and quality of life -its prevalence is high and rising in many countries.
[55] Childhood obesity can have detrimental health and wellbeing implications during childhood and is a major predictor of obesity in adulthood and its serious and expensive associated conditions. [5] Community-based strategies have been effective in achieving some reductions in population BMI, but these have not been sustained. The WHO STOPS intervention builds on this evidence base. It seeks to harness existing community resources and expand the extent of local engagement in obesity-risk reduction, across whole communities.
Evaluating the cost-effectiveness of this novel systems-based intervention will help policymakers by assessing the resource use implications of achieving any observed intervention effect. This protocol considers the main challenges posed by the economic evaluation of such a complex intervention designed to produce systems change. This protocol registers our intent to conduct this evaluation alongside the WHO STOPS Childhood Obesity Trial, and describes for transparency, the predetermined approaches for addressing the methodological challenges described and the analyses planned a priori. This does not preclude additional hurdles arising during the course of the project forcing additions to or deviations from this plan, but these will be openly documented during the reporting of results. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
